Skip to main content

The ideal tender excellence journey for the Life Sciences

  • After download go to: Resource Library
  • Speakers: Pol Vanaerde - President - EPP; George Boretos - Co-founder & Co-CEO - Cube RM; Laura Wardoyo - Director, Global Head of Tenders & Pricing - Bavarian Nordic; Nico Bacharidis - Business Advisor Cube RM , Founder & CEO - Growthpal
  • Free Video: No
  • VLT Viewable: Yes

EPP Dynamic Talk in partnership with Cube RM "The Ideal Tender Excellence Journey for the Life Sciences"

  • 7 steps for success in Tendering Framework with George Boretos, Co- Founder & Co-CEO - Cube RM                - Managing end - to - end the tender cycle, from Tender Discovery to Awardation.                - Enabling technologies for Tendering Excellence.
  •  Tender Industry Benchmarking & Key Challenges with Nico Bacharidis, Business Advisor - Cube RM, Founder & CEO – Growpal                - Key success factors for tendering in Life Sciences                - Current status of the market (industry benchmarks)
  • ️ Using Innovative Technologies to excel in Tendering with Laura Wardoyo, Director – Global Head of Tenders & Pricing – Bavarian Nordic                - Key company challenges                - The implemented solution and key benefits
  •  
  • Panel with the President of the EPP (Pol Vanaerde) moderating the discussion
  •            

Life Sciences, 2022, Recorded Dynamic Talks

  • Hits: 1041

Dynamic Talk Life Sciences Session 4 - Pricing Innovation: how is value creation and digitisation taking MedTech pricing and reimbursement models to the next level?

  • After download go to: Resource Library
  • Speakers: Marco Marchetti, Director, HTA Uni, National Agency for Regional HealthCare Services (Italy); Reginald Lassagne, Senior Director, Head of Global Strategic Pricing & Reimbursement, LivaNova; Kyle Forcier, Senior Director, Life Sciences Product Marketing, Model N; MODERATOR: Ian Tidswell, Founder & Lead Consultant, EEN Consulting GMBH
  • Free Video: No
  • VLT Viewable: Yes

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

  • Value-based pricing and contracting for innovative MedTech: assessing main barriers and opportunities
  •    
  • How are payers embracing digital health tools such as connected devices and telemedicine? Exploring reimbursement models for digital health products with country-focused examples
  •    
  • Learning how to successfully achieve payer reimbursement with outcomes-based risk-sharing models.
  •    
  • From Device-Focused to Service-Focused: capturing the value-based procurement opportunity to get ahead in a competitive marketplace

Life Sciences, 2022, Recorded Dynamic Talks

  • Hits: 1008

Dynamic Talk Life Sciences Session 3 - Bidding to win: Key success factors in global tender management and contracting

  • After download go to: Resource Library
  • Speakers: George Boretos, Co-Founder & Co-CEO, Cube RM & Laura Wardoyo, Director Global Head of Tenders & Pricing, Bavarian Nordic; Muge Gurevin, META Commercial Policy & Pricing Head, Philips; Ruven Remo Eul, Principal – Life Sciences, Marbls; Silvia de Angelis, Strategic Pricing and Tender Manager, Johnson & Johnson Vision; MODERATOR: Elisabete Nunes Gonçalves, Assistant Director, HTA & Market Access, Real World and Late Phase, CTI Clinical Trial and Consulting Group
  • Free Video: No
  • VLT Viewable: Yes

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

  • Exploring real-life examples of successful tendering in medical devices and pharmaceuticals
  •    
  • EValue-based tendering in Life Sciences: assessing challenges and opportunities for adding quality criteria beyond price-only evaluation of tenders
  •    
  • Leveraging latest technologies to evaluate tender opportunities and find the optimal price for the product

Life Sciences, 2022, Recorded Dynamic Talks

  • Hits: 993

Dynamic Talk Life Sciences Session 2 - Harnessing the power of Big Data and AI in Market Access and Pricing

  • After download go to: Resource Library
  • Speakers: Rodney Emerson, Executive Director, Pricing and Contracts, Sandoz; Alejandra Garitonandía, Industry Principal EMEA, Vistex; Claudia Vaz, Director Digital Innovation, Roche Diagnostics International; Israel Rodrigo, Business Consultant, Vendavo; MODERATOR: Ruven Remo Eul, Principal – Life Sciences, Marbls
  • Free Video: No
  • VLT Viewable: Yes

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

  • Why a strategic approach is key to digital transformation: from the adoption and implementation of advanced technologies to organisational changes, collaboration, and supportive leadership
  •    
  • How is big data and AI technology driving market access strategy and practice? How can AI and machine learning help maximise clinical trial data, identify RWE gaps and generation of evidence to meet HTA requirements?
  •    
  • Assessing how predictive analytics can be deployed to inform pricing strategies, determine appropriate launch sequences, and optimise discounts

Life Sciences, 2022, Recorded Dynamic Talks

  • Hits: 978

Dynamic Talk Life Sciences Session 1 - Developing an effective market access strategy to tackle growing pricing pressures in a challenging reimbursement environment

  • After download go to: Resource Library
  • Speakers: Giovanni Tafuri, Director International Market Access and Policy, Apellis Pharmaceuticals; Alan Crowther, General Manager, Global Pricing & Access Solutions, Eversana; Natasa Zibelnik, Global Head of Access, Value and Pricing, EUSA Pharma; Mercedes Prior, International Market Access Director, Grifols; MODERATOR: Elisabete Nunes Gonçalves, Assistant Director, HTA & Market Access, Real World and Late Phase, CTI Clinical Trial and Consulting Group
  • Free Video: No
  • VLT Viewable: Yes

During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;

  • From greater adoption of Real-World Evidence to Joint EU HTA and increased cross-border collaboration – what’s the impact of new Market Access and Pricing trends in Europe in a post-pandemic economy?
  •    
  • Pricing and Market Access launch excellence: identifying key drivers and challenges for a successful launch in a climate of change
  •    
  • Assessing the side effects of greater Net Price Transparency for innovative medicines in Europe – adverse pricing consequences or perceived price fairness?

Open / In Class, 2020, Recorded Dynamic Talks

  • Hits: 1041